Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorKarataş, Mert Olgun
dc.contributor.authorUslu, Harun
dc.contributor.authorAlıcı, Bülent
dc.contributor.authorGökçe, Başak
dc.contributor.authorGencer, Nahit
dc.contributor.authorArslan, Oktay
dc.contributor.authorArslan, N. Burcu
dc.contributor.authorÖzdemir, Namık
dc.date.accessioned2019-10-17T11:48:55Z
dc.date.available2019-10-17T11:48:55Z
dc.date.issued2016en_US
dc.identifier.issn0968-0896
dc.identifier.issn1464-3391
dc.identifier.urihttps://doi.org/ 10.1016/j.bmc.2016.02.012
dc.identifier.urihttps://hdl.handle.net/20.500.12462/8754
dc.descriptionGencer, Nahit (Balikesir Author)en_US
dc.description.abstractParaoxonase (PON) is a key enzyme in metabolism of living organisms and decreased activity of PON1 was acknowledged as a risk for atherosclerosis and organophosphate toxicity. The present study describes the synthesis, characterization, PON1 inhibitory properties and molecular docking studies of functionalized imidazolium and benzimidazolium salts (1a-5g). The structures of all compounds were elucidated by IR, NMR, elemental analysis and structures of compounds 2b and 2c were characterized by single-crystal X-ray diffraction. Compound 1c, a coumarin substituted imidazolium salt showed the best inhibitory effect on the activity of PON1 with good IC50 value (6.37 mu M). Kinetic investigation was evaluated for this compound and results showed that this compound is competitive inhibitor of PON1 with K-1, value of 2.39 mu M. Molecular docking studies were also performed for most active compound 1c and one of least active compound 2c in order to determine the probable binding model into active site of PON1 and validation of the experimental results.en_US
dc.language.isoengen_US
dc.publisherPergamon-Elsevier Science Ltden_US
dc.relation.isversionof10.1016/j.bmc.2016.02.012en_US
dc.rightsinfo:eu-repo/semantics/embargoedAccessen_US
dc.subjectBenzimidazoliumen_US
dc.subjectCoumarinen_US
dc.subjectImidazoliumen_US
dc.subjectInhibitionen_US
dc.subjectMolecular Dockingen_US
dc.subjectParaoxonase 1en_US
dc.titleFunctionalized imidazolium and benzimidazolium salts as paraoxonase 1 inhibitors: Synthesis, characterization and molecular docking studiesen_US
dc.typearticleen_US
dc.relation.journalBioorganic & Medicinal Chemistryen_US
dc.contributor.departmentFen Edebiyat Fakültesien_US
dc.contributor.authorID0000-0001-8827-8557en_US
dc.contributor.authorID0000-0001-8827-8557en_US
dc.contributor.authorID0000-0003-3371-9874en_US
dc.contributor.authorID0000-0001-7092-8857en_US
dc.identifier.volume24en_US
dc.identifier.issue6en_US
dc.identifier.startpage1392en_US
dc.identifier.endpage1401en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster